Urgent transcatheter aortic valve implantation in an all-comer population: a single-centre experience

Table 2 Uni- and multivariable Cox regression analysis

	Hazard ratio	CI 95%	p-value	Hazard ratio	CI 95%	p-value
Patient characteristics
Age	1.006	0.967–1.048	0.761	1.008	0.967–1.051	0.699
Gender	0.968	0.5931–1.581	0.897	0.993	0.595–1.657	0.978
Height	0.981	0.954–1.010	0.196
Weight	0.984	0.966–1.003	0.093
BMI	0.968	0.914–1.025	0.267
DM	0.877	0.498–1.544	0.649
Prior stroke	0.299	0.073–1.223	0.093
COPD	1.551	0.844–2.852	0.158
Creatinine	1.002	0.998–1.006	0.361
GFR	0.989	0.975–1.003	0.111
GFR < = 30	0.859	0.502–1.468	0.577
LVEF < = 30	2.109	0.962–4.624	0.062
Cardiac surgery	0.866	0.471–1.591	0.642
Hospitalisation and procedural risk
Euroscore II	1.075	1.030–1.122	0.001
Urgency	3.771	2.114–6.727	< 0.0001	3.447	1.919–6.192	0.001
Apical access	2.086	1.262–3.447	0.004	1.882	1.123–3.155	0.016
Days to discharge*	1.055	1.030–1.081	< 0.0001
Complications
Major stroke	4.815	1.931–12.007	0.001	4.346	1.685–11.212	0.002
Renal failure	6.909	1.688–28.283	0.007	4.055	0.960–17.133	0.057
Pacemaker implantation	1.359	0.531–3.482	0.522

Significant differences are in bold
Complication-stroke: symptomatic cerebrovascular event, which leads to registration in the local complication database. Complication-renal failure: a decline in kidney function, which was significant enough to be registered in the local complication database
BMI, Body Mass Index; DM, diabetes mellitus; CVE, cerebrovascular event in the medical history; COPD, Chronic Obstructive Lung Disease; LVEF, Left ventricular ejection fraction; PM, pacemaker
*Days from TAVI to discharge

ISSN: 1471-2261